Clinical Trial

Treatment of Overactive Bladder With Anticholinergic Agents

Name: Treatment of Overactive Bladder With Anticholinergic Agents — clinical trial record (NCT07046156)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting

View on ClinicalTrials.gov →

Summary

This study aims to evaluate the efficacy and adverse effect incidence of three different anticholinergics (oxybutinin, propiverine, and tolterodine) that are used in children with overactive bladder.

Trial Details

NCT Number	NCT07046156
Lead Sponsor	Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital
Conditions	Overactive Bladder
Enrollment	120 participants
Start Date	2022-09-01
Primary Completion	2025-06-30 (estimated)
Study Completion	2026-06-01 (estimated)
Updated on ClinicalTrials.gov	2025-07-01